Platelet Aggregation Test: Medication Hold Guidelines for Accurate Results

Platelet function testing (light transmission aggregometry, VerifyNow, PFA-100/200) requires temporary discontinuation of agents that inhibit platelet activation. Never stop medications without consulting the ordering physician.

Standard Hold Intervals (General Guidance)

Drug Class / AgentTypical HoldNotes
Aspirin (irreversible COX-1)7–10 daysPlatelet turnover ~10%/day; 7 days = ~50% new platelets
P2Y12 inhibitors
Clopidogrel5–7 daysIrreversible; platelet turnover
Prasugrel7 daysIrreversible
Ticagrelor3–5 daysReversible; faster offset
Cangrelor (IV)1–2 hoursVery short half-life
NSAIDs (reversible COX)48–72 hours≥5 half-lives; ibuprofen 24h may suffice but 48h safer
GP IIb/IIIa inhibitors (IV)4–8 hours (abciximab 24–48h)Eptifibatide/tirofiban: short; abciximab: long (Fc fragment)
Anticoagulants (warfarin, DOACs, heparin)Usually NOT heldDo not affect platelet aggregation directly; but bleeding risk if invasive. Consult.
CorticosteroidsVariableMay affect platelet adhesiveness; discuss with hematologist
SSRIs/SNRIs2–4 weeksImpair platelet serotonin uptake; long washout
Herbals (ginkgo, garlic, ginger, ginseng, fish oil >3g)7–10 daysAntiplatelet effects documented
Dipyridamole, cilostazol48–72 hoursPDE inhibition
Vorapaxar4–6 weeksLong half-life (PAR-1 antagonist)

Critical Considerations

  • Thrombotic risk vs. test urgency: In stent patients (especially <12 months), holding P2Y12 may cause stent thrombosis. Test may be deferred or done on therapy with interpretation caveats.
  • Test type matters: VerifyNow P2Y12 assay specifically measures P2Y12 inhibition; LTA with multiple agonists gives broader profile.
  • Document all meds/supplements including OTC and herbals.
  • Repeat testing after washout if initial result ambiguous.

Prescription Medications - Related Articles